After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Ozempic, a prescription drug typically used to manage type 2 diabetes, is fast turning into an answer for quick weight loss ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...

Medically reviewed by Mary Choy, PharmD Some people who take Ozempic (semaglutide)—a drug for diabetes management and weight ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

Poor diet, environmental toxins, unhealthy habits and pharmaceuticals are contributing to a national rise in chronic ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss ...